免疫疗法:我们应该担心免疫衰变吗?
Asli Özkan1, Nienke A de Glas1,2, Johanneke E A Portielje1
1Department of Medical Oncology, Department of Medical Oncology, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.
Ageing and cancer research & treatment
|January 19, 2026
概括
随着全球人口的老龄化,了解免疫衰老 (与年龄相关的免疫衰退) 对于优化癌症免疫治疗至关重要. 这项研究探讨了它对老年患者治疗反应和不良事件的影响.
科学领域:
- 老年瘤学 老年瘤学
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 全球人口老龄化,导致老年人癌症发病率增加.
- 免疫检查点抑制剂 (ICI) 被广泛使用,但它们在老年患者中的有效性和安全性受免疫衰变的影响,即与年龄相关的免疫功能下降.
- 在这个人群中,免疫疗法耐药性和严重的免疫相关不良事件 (irAEs) 仍然存在挑战.
研究的目的:
- 探索免疫性和ICI治疗在老年和脆弱的癌症患者的疗效和安全性之间的复杂关系.
- 突出研究的需要,将免疫衰变标记与治疗结果和irAEs相关联.
- 强调了解这些因素对于推进老年瘤学的重要性.
主要方法:
- 这篇评论回顾了现有的文献,并讨论了免疫性,脆弱性和ICI治疗之间的相互关系.
- 它的重点是外周血液免疫突变标记物对瘤微环境 (TME) 和治疗反应的潜在影响.
- 该审查还考虑了老年患者中irrAEs的发生和管理.
主要成果:
- 目前对免疫衰变标志物与老年人ICI治疗结果或irAEs之间的直接相关性进行的研究有限.
- 假设免疫性产生会影响免疫治疗的有效性和不良事件的风险.
- 了解这些关联对于预测患者反应和管理副作用至关重要.
结论:
- 识别可靠的免疫性生物标志物对于分层老年患者进行ICI治疗至关重要.
- 需要个性化治疗方法来改善老年瘤学的结果并最大限度地降低风险.
- 进一步的研究至关重要,以阐明免疫发育在癌症免疫治疗中对老年人和脆弱人群的作用.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
06:51Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
15.9K
We describe an approach to reliably generate chimeric antigen receptor (CAR) T cells and test their differentiation and function in vitro and in...
15.9K
16:56Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
17.5K
The present work illustrates the convenience of using sublingual immunotherapy to boost the innate immune response in the lungs and confer protection against acute pneumococcal pneumonia in...
17.5K
08:06Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
20.2K
An experimental lung metastasis and CTL immunotherapy mouse model for analysis of tumor cells-T cell interaction in...
20.2K
05:01Multiplexed Immunofluorescence Imaging to Analyze Immunotherapy-Resistant T Cell Subpopulations
672
This video demonstrates an in-situ fluorescence multispectral imaging technique to analyze different subpopulations of infiltrating T cells in tumor tissue. A renal cell carcinoma tissue cryosection is treated with antibodies to label CD8+ T cells that express specific inhibitory receptors and exhibit an immunotherapy-resistant phenotype. The labeled section is visualized using a multispectral microscope to identify the distinct CD8+ T cell...
672
08:40Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
18.6K
The most commonly used method for generating large numbers of autologous dendritic cells (DCs) for use in tumor immunotherapy is described. The method uses IL-4 and GM-CSF to differentiate DCs from monocytes. The immature DCs are stimulated to mature and then loaded with antigens before they are injected back into the...
18.6K

